1. ‘Prophylactic’ Treatment of Meningeal Leukemia in Children by Intrathecal Methotrexate
- Author
-
Muslichan S, Abdulsalam M, Wahidijat I, Odang O, and A. H. Markum
- Subjects
Male ,Oncology ,medicine.medical_specialty ,Survival period ,Remission, Spontaneous ,Central nervous system ,Intrathecal methotrexate ,Meninges ,Central Nervous System Diseases ,Internal medicine ,medicine ,Humans ,Child ,Injections, Spinal ,Cerebrospinal Fluid ,Brain Diseases ,Mercaptopurine ,business.industry ,Bone Marrow Examination ,Hematology ,General Medicine ,medicine.disease ,Leukemia, Lymphoid ,Leukemia ,Methotrexate ,medicine.anatomical_structure ,Vincristine ,Child, Preschool ,Female ,business ,Meningeal Leukemia ,medicine.drug ,Prophylactic treatment - Abstract
The survival period of children suffering from leukemia could be prolonged by using the new antileukemic agents. On the other hand, the frequency of central nervous system involvement as a complicatio
- Published
- 1972
- Full Text
- View/download PDF